Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale

Attila Makkos, Márton Kovács, Dávid Pintér, J. Janszky, N. Kovács

Research output: Contribution to journalArticle

Abstract

Background: Motor complications represent an important clinical problem in the treatment of Parkinson's disease (PD). The Motor Complications Part of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS Part IV) and the Unified Dyskinesia Rating Scale (UDysRS) are among the most reliable instruments to evaluate these problems. The minimal clinically important difference thresholds are the smallest changes in the outcome measures that are clinically meaningful. Aims: The aim of our study was to calculate the minimal clinically important difference thresholds for the MDS-UPDRS Part IV and the historic parts of the UDysRS. Methods: A total of 1044 paired investigations of 436 patients were analyzed. Changes in the respective outcome measures (MDS-UPDRS Part IV, UDysRS Parts I and II) were compared to the Patient-rated Global Impression of Improvement scores (anchors). Subsequently, we applied receiver-operating characteristic analysis to ascertain the MCID thresholds with optimal sensitivity and specificity. Results: Any improvement greater than 2.1 points or any worsening greater than 1.8 points on UDysRS Part I represents a minimal, yet clinically meaningful change. In reference to UDysRS Part II, the smallest changes considered clinically relevant are 1.8 and 1.7 points for improvement and deterioration, respectively. The thresholds for the MDS-UPDRS Part IV are 0.9 points for improvement and 0.8 points for worsening. Conclusions: Our estimates may allow the judgment of the clinical relevance of numeric changes in the dyskinesia scales.

Original languageEnglish
JournalParkinsonism and Related Disorders
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Dyskinesias
Parkinson Disease
Outcome Assessment (Health Care)
ROC Curve
Minimal Clinically Important Difference
Sensitivity and Specificity

Keywords

  • Minimal but clinically relevant differences
  • Minimal clinically important changes
  • Parkinson disease
  • Receiver operating characteristic curve
  • Unified Dyskinesia Rating Scale

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale. / Makkos, Attila; Kovács, Márton; Pintér, Dávid; Janszky, J.; Kovács, N.

In: Parkinsonism and Related Disorders, 01.01.2018.

Research output: Contribution to journalArticle

@article{4ee0537442b94d62967b2bb9db177a51,
title = "Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale",
abstract = "Background: Motor complications represent an important clinical problem in the treatment of Parkinson's disease (PD). The Motor Complications Part of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS Part IV) and the Unified Dyskinesia Rating Scale (UDysRS) are among the most reliable instruments to evaluate these problems. The minimal clinically important difference thresholds are the smallest changes in the outcome measures that are clinically meaningful. Aims: The aim of our study was to calculate the minimal clinically important difference thresholds for the MDS-UPDRS Part IV and the historic parts of the UDysRS. Methods: A total of 1044 paired investigations of 436 patients were analyzed. Changes in the respective outcome measures (MDS-UPDRS Part IV, UDysRS Parts I and II) were compared to the Patient-rated Global Impression of Improvement scores (anchors). Subsequently, we applied receiver-operating characteristic analysis to ascertain the MCID thresholds with optimal sensitivity and specificity. Results: Any improvement greater than 2.1 points or any worsening greater than 1.8 points on UDysRS Part I represents a minimal, yet clinically meaningful change. In reference to UDysRS Part II, the smallest changes considered clinically relevant are 1.8 and 1.7 points for improvement and deterioration, respectively. The thresholds for the MDS-UPDRS Part IV are 0.9 points for improvement and 0.8 points for worsening. Conclusions: Our estimates may allow the judgment of the clinical relevance of numeric changes in the dyskinesia scales.",
keywords = "Minimal but clinically relevant differences, Minimal clinically important changes, Parkinson disease, Receiver operating characteristic curve, Unified Dyskinesia Rating Scale",
author = "Attila Makkos and M{\'a}rton Kov{\'a}cs and D{\'a}vid Pint{\'e}r and J. Janszky and N. Kov{\'a}cs",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.parkreldis.2018.08.018",
language = "English",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale

AU - Makkos, Attila

AU - Kovács, Márton

AU - Pintér, Dávid

AU - Janszky, J.

AU - Kovács, N.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Motor complications represent an important clinical problem in the treatment of Parkinson's disease (PD). The Motor Complications Part of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS Part IV) and the Unified Dyskinesia Rating Scale (UDysRS) are among the most reliable instruments to evaluate these problems. The minimal clinically important difference thresholds are the smallest changes in the outcome measures that are clinically meaningful. Aims: The aim of our study was to calculate the minimal clinically important difference thresholds for the MDS-UPDRS Part IV and the historic parts of the UDysRS. Methods: A total of 1044 paired investigations of 436 patients were analyzed. Changes in the respective outcome measures (MDS-UPDRS Part IV, UDysRS Parts I and II) were compared to the Patient-rated Global Impression of Improvement scores (anchors). Subsequently, we applied receiver-operating characteristic analysis to ascertain the MCID thresholds with optimal sensitivity and specificity. Results: Any improvement greater than 2.1 points or any worsening greater than 1.8 points on UDysRS Part I represents a minimal, yet clinically meaningful change. In reference to UDysRS Part II, the smallest changes considered clinically relevant are 1.8 and 1.7 points for improvement and deterioration, respectively. The thresholds for the MDS-UPDRS Part IV are 0.9 points for improvement and 0.8 points for worsening. Conclusions: Our estimates may allow the judgment of the clinical relevance of numeric changes in the dyskinesia scales.

AB - Background: Motor complications represent an important clinical problem in the treatment of Parkinson's disease (PD). The Motor Complications Part of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS Part IV) and the Unified Dyskinesia Rating Scale (UDysRS) are among the most reliable instruments to evaluate these problems. The minimal clinically important difference thresholds are the smallest changes in the outcome measures that are clinically meaningful. Aims: The aim of our study was to calculate the minimal clinically important difference thresholds for the MDS-UPDRS Part IV and the historic parts of the UDysRS. Methods: A total of 1044 paired investigations of 436 patients were analyzed. Changes in the respective outcome measures (MDS-UPDRS Part IV, UDysRS Parts I and II) were compared to the Patient-rated Global Impression of Improvement scores (anchors). Subsequently, we applied receiver-operating characteristic analysis to ascertain the MCID thresholds with optimal sensitivity and specificity. Results: Any improvement greater than 2.1 points or any worsening greater than 1.8 points on UDysRS Part I represents a minimal, yet clinically meaningful change. In reference to UDysRS Part II, the smallest changes considered clinically relevant are 1.8 and 1.7 points for improvement and deterioration, respectively. The thresholds for the MDS-UPDRS Part IV are 0.9 points for improvement and 0.8 points for worsening. Conclusions: Our estimates may allow the judgment of the clinical relevance of numeric changes in the dyskinesia scales.

KW - Minimal but clinically relevant differences

KW - Minimal clinically important changes

KW - Parkinson disease

KW - Receiver operating characteristic curve

KW - Unified Dyskinesia Rating Scale

UR - http://www.scopus.com/inward/record.url?scp=85054135846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054135846&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2018.08.018

DO - 10.1016/j.parkreldis.2018.08.018

M3 - Article

C2 - 30174275

AN - SCOPUS:85054135846

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

ER -